Cortecs International Ltd., University of Canberra, Australia deal

DLVRY and the university will collaborate to develop an oral therapeutic vaccine against otitis media (inflammation in the middle ear). DLVRY (London) will provide an undisclosed amount of funding and royalties on sales in return for exclusive marketing rights to intellectual property arising from the study. ...